Navigation Links
Syngenta Crop Protection Canada announces seed treatment project with Innovotech
Date:3/22/2010

GUELPH, ONTARIO--(Marketwire - March 17, 2010) - Syngenta Crop Protection Canada, Inc. today announced its intent to work with Innovotech (TSX VENTURE:IOT), a Canadian biotechnology product development company, clearing the way for continued research trials in North America on the new plant bacterial blight research product, oxysilver nitrate.

Earlier this year Innovotech and Syngenta entered into a mutually beneficial agreement by which Syngenta will conduct research trials of oxysilver nitrate in a seed treatment application for control of bacterial blight.

"We are very pleased to play a part in the development of this new technology," said Coby Long, North American Seed Care marketing head at Syngenta. "We believe it is important to continually seek out new innovative pest management solutions for producers, both in North America and worldwide."

Bacteria, like fungi, exist in the soil as part of a dynamic agricultural system. Dry beans as well as other crops, can be greatly affected by bacterial diseases. Bacterial blight is a serious problem for many crops with very few acceptable control products available to Canadian producers.


'/>"/>

Contact: Ken Boutilier
ken.boutilier@innovotech.ca
780-448-0585
Innovotech Inc.
Source:Eurekalert

Page: 1

Related biology news :

1. IVCC and Syngenta start project for novel insecticidal active ingredient for malaria control
2. Study details machinery of immune protection against inflammatory diseases like colitis
3. SeaWeb applauds US decision to support bluefin tuna trade protection
4. World-class protection boosts Australias Great Barrier Reef
5. Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics
6. Nanotech protection
7. Uniloc Unveils Industry-First Authentication Technology for Comprehensive Protection of Critical Infrastructure
8. Uniloc Unveils Industry-First Authentication Technology for Comprehensive Protection of Critical Infrastructure
9. Combating Terrorism with Commercial Technology: 2009 Force Protection Equipment Demonstration
10. UT Southwestern researchers probe kidney damage, protection in lupus
11. Case Western Reserve University receives $1.66m grant from NIH for otoprotection research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 15, 2014 Research and ... the addition of the "Samsung Galaxy S5 ... report to their offering. ... a totally different sensing technology than the iPhone ... fingerprint sensor in its product. The ...
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... the full text of the press releases and the ... note that all news releases are embargoed until Thursday, ... BREAST CANCER PATIENTS WHO WILL RESPOND TO CHEMOTHERAPY , ... genetic signature that can predict which breast cancer patients ...
... are characterized by poor vegetative cover, strong winds, ... this context, the land resources of Abu Dhabi ... to various land degradation stresses, including wind erosion, ... land resources of Abu Dhabi Emirate, land degradation ...
... in French . , Montreal, May 6, ... pregnancy, affecting more than 80 percent of future mothers. ... that hospitalization is required. Yet a new ... appears effective in improving symptoms more quickly and provides ...
Cached Biology News:IMPAKT -- Breast cancer conference highlights 2Wind, salt and water are leading indicators of land degradation in Abu Dhabi 2Treatment for extreme nausea, vomiting during pregnancy 2
(Date:12/24/2014)... The report expects global cell isolation and expansion ... provides a carefully analyzed data about the vital drivers, ... , Full Copy of Report @ http://bit.ly/1yUxy0T ... cell expansion will keep witnessing growth at an impressive ... be driven by rapid technological advancements, government funding and ...
(Date:12/24/2014)... 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR ... December 22, 2014, thereby completing the U.S. HSR ... acquisition of the Company by Merck KGaA, Darmstadt, ... another condition to closing the transaction, which remains ...
(Date:12/22/2014)... RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a ... of autologous cell therapies, announced today the publication of ... conjunction with co-authors from Kyoto University and the University ... clinical research using dermal sheath cup (DSC) cells to ... paper entitled " Hair Follicle Dermal Stem Cells Regenerate ...
(Date:12/22/2014)... ITRA Global, one of the largest organizations ... estate, has further expanded its global reach with the ... Western Australia, reports Mylinda Vick, CCIM, Chairman of the ... / ACORPP (Australian Corporate Property and Projects) , is ... services to a wide range of clients in the ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... New Best Practice Statements Were Presented at the ... YOKNEAM, Israel and PLYMOUTH MEETING, Pennsylvania, May 21 ... announced today that the,American Urological Association has introduced ... The guidelines state,that cryoablation is a treatment option ...
... Sweden, May 21 At the 14th ... 18-22, over 500 participants,including neurosurgeons, radiation oncologists ... for treatment of tumors and other,brain disorders ... in Quebec,Canada. During the meeting, 260 oral ...
... First Diagnostic Test Based on Company,s microRNA Technology Submitted for, Regulatory Approval to ... ... Validate and Offer Tests Based ... Two Additional microRNA-Related ...
Cached Biology Technology:American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients 2American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients 3Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada 2Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada 3Rosetta Genomics Reports First Quarter 2008 Financial Results 2Rosetta Genomics Reports First Quarter 2008 Financial Results 3Rosetta Genomics Reports First Quarter 2008 Financial Results 4Rosetta Genomics Reports First Quarter 2008 Financial Results 5Rosetta Genomics Reports First Quarter 2008 Financial Results 6Rosetta Genomics Reports First Quarter 2008 Financial Results 7Rosetta Genomics Reports First Quarter 2008 Financial Results 8Rosetta Genomics Reports First Quarter 2008 Financial Results 9Rosetta Genomics Reports First Quarter 2008 Financial Results 10
Bis-Acrylamide (bis) is a monomer used as a crosslinker with acrylamide to form polyacrylamide electrophoretic gels. This 2% bis solution is supplied as 500 ml....
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
Mouse monoclonal antibody to Lats2....
Goat polyclonal to Lipocalin 2...
Biology Products: